Oh, The Places Dermatology Will Go in 2024!
The Dermatology Digest
FEBRUARY 8, 2024
This will be a game-changer if it pans out and may get us closer to disease cures via optimization of existing biological therapies,” he says. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.” Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., And the Skin Disease of the Year Is….
Let's personalize your content